Amgen Inc is set to buy biotech firm Horizon Therapeutics Plc at a valuation of about $26 billion in what would be its largest acquisition, Bloomberg News reported on Monday.
Amgen and Horizon did not immediately respond to Reuters' requests for comments.The Wall Street Journal firstReporting by Abinaya Vijayaraghavan in Bengaluru; Editing by Rashmi Aich.
Amgen and Horizon did not immediately respond to Reuters' requests for comments.The Wall Street Journal firstReporting by Abinaya Vijayaraghavan in Bengaluru; Editing by Rashmi AichSouth Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Amgen reportedly in talks to buy Horizon TherapeuticsThe U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.
Read more »
Amgen emerges frontrunner in Horizon deal as Sanofi drops bidAmgen Inc is in advanced talks to buy biotech company Horizon Therapeutics Plc , the Wall Street Journal reported on Sunday, while rival bidder French health group Sanofi announced it had dropped its bid.
Read more »
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsAmgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion
Read more »
‘Violent Night’ Passes $26 Million at Domestic Box Office'Violent Night' has passes $26 million at the domestic box office.
Read more »
Sanofi says it does not intend to make an offer for HorizonFrench health group Sanofi said on Sunday that it no longer intends to make an offer for Horizon Therapeutics Plc.
Read more »
Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Read more »